BioConst生物常量

僅供研究與科普參考,會持續修訂但可能存在錯誤;任何診斷、用藥、檢查或治療決定請遵循醫師指導。

脂肪肝與肝脂肪沉積

肝內脂肪可反映代謝語境,並需要結合纖維化風險理解。

需要醫師參與解讀的頁面

這個主題可能涉及檢查或影像解讀、神經、心臟、血液、肝、腎、肺、手術、用藥或複雜基礎病情況。BioConst 只做解釋,不提供個人判斷或處置建議。

這是什麼

Fatty liver disease means fat is present in the liver and is interpreted with metabolic and fibrosis context.[1,2]

大家可能感知到什麼

  • NAFLD is also referred to as MASLD in NIDDK patient material.[1,2]
  • Blood tests, imaging, and sometimes biopsy may enter diagnosis and staging context.[1,2]

關鍵變數

Hepatic steatosis

Fat in the liver is the structural starting point.[1,2]

Alanine aminotransferase (ALT)

ALT may be elevated, but enzymes alone do not determine severity.[1,2]

Liver fibrosis

Fibrosis context changes the meaning of fatty liver.[1,2]

為什麼會發生

  • Metabolic factors such as obesity, insulin resistance, diabetes, triglycerides, and metabolic syndrome can increase risk.[1,2]
  • Other causes of liver fat and alcohol-associated liver disease need clinical separation.[1,2]

臨床應對方向

  • Clinical teams may use history, exam, labs, imaging, and specialist review depending on fatty liver context.[1,2]
  • BioConst explains the map and does not diagnose, rank urgency, choose tests, or recommend treatment.[1,2]

常見誤區

  • Fat on imaging does not automatically identify inflammation.[1,2]
  • Normal enzymes do not automatically exclude clinically important disease.[1,2]
  • Fatty liver is not a supplement target or a one-number problem.[1,2]

相關 wiki 變數